Stryker Corporation reports developments as a global medical technology company serving MedSurg, Neurotechnology and Orthopaedics markets. Company news commonly covers operating results, organic sales trends, segment performance, dividends, shareholder-meeting activity and executive finance or investor-relations appointments.
Stryker updates also address portfolio expansion across medical devices, implants, instruments, operating-room equipment, neurotechnology and vascular solutions. Recent corporate activity includes the completed acquisition of Amplitude Vascular Systems, adding an intravascular lithotripsy platform for peripheral arterial disease to Stryker's peripheral vascular portfolio.
Stryker (NYSE:SYK) has scheduled its second quarter 2025 financial results announcement for Thursday, July 31, 2025. The company will release its Q2 2025 earnings press release at approximately 4:05 p.m. ET, followed by a webcast discussion at 4:30 p.m. ET. The webcast will be accessible through Stryker's Events & Presentations webpage, with an archive available two hours after the live call concludes.
Stryker (NYSE:SYK) has received FDA 510(k) clearance for its Incompass® Total Ankle System, designed for patients with severe ankle joint conditions. The system integrates technologies from Stryker's Inbone® and Infinity® systems into a comprehensive solution for total ankle replacement.
The innovative platform incorporates Adaptis® Boney Ingrowth Technology and is informed by data from over 85,000 CT scans and 100,000 clinical cases. Built using the SOMA platform and Prophecy Surgical Planning System, Incompass features redesigned instrumentation, improved alignment systems, and streamlined surgical workflow to enhance procedural efficiency and patient-specific care.
Stryker (NYSE:SYK) has announced its quarterly dividend declaration of $0.84 per share. The dividend will be payable on July 31, 2025, to shareholders of record as of June 30, 2025. This dividend amount represents a 5.0% increase compared to the previous year while remaining unchanged from the last quarter's distribution.
Stryker (NYSE:SYK) has announced its participation in the upcoming Bank of America Securities 2025 Global Healthcare Conference. The event will take place on Tuesday, May 13, 2025, at the Encore at Wynn Hotel in Las Vegas, Nevada.
Key details:
- Presenters: Preston Wells (Vice President and Chief Financial Officer) and Jason Beach (Vice President, Finance and Investor Relations)
- Presentation Time: 1:40 p.m. Pacific Time
- Access: Live webcast and replay available on www.stryker.com
- Availability: Recording will be archived on the Investor Relations page
Stryker (NYSE:SYK) has scheduled its first quarter fiscal year 2025 financial results announcement for Thursday, May 1, 2025. The company will release a press release containing summary financial information at approximately 4:05 p.m. ET, covering the quarter ending March 31, 2025.
A webcast to discuss the Q1 2025 results will be held at 4:30 p.m. ET on the same day. The webcast will be accessible through Stryker's Events & Presentations webpage, with an archive available on the company's website two hours after the live call concludes.
Stryker (NYSE: SYK) has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, , which will operate under the newly formed VB Spine, . The strategic divestment aims to enhance Stryker's focus and enable investments in areas with greater innovation and growth potential.
As part of the agreement, VB Spine will have exclusive access to Mako Spine and Copilot technologies for spine procedures. Stryker maintains its presence in the spine sector through its Interventional Spine, Neurotechnology, and Enabling Technologies businesses, along with a strategic partnership with VB Spine.
The transaction's international component will be executed in phases, with transfers to VB Spine in certain markets pending legal, regulatory, and employee consultation requirements.
Stryker (NYSE:SYK) has nominated Emmanuel "Manny" Maceda to its board of directors, with the election scheduled for the Annual Meeting of Shareholders on May 8, 2025. Maceda brings over 30 years of experience in leading organizations and advising executives on corporate transformations.
Maceda currently serves as Chairman of Bain & Company, following his role as Worldwide Managing Partner and CEO from 2018 to 2024. During his leadership, he drove Bain's global transformation across 50+ offices, strengthening digital capabilities and expanding sustainability focus. Since joining Bain in 1989, he has held various senior leadership positions and advised CEOs on strategy, growth, and organizational effectiveness.
Stryker (NYSE:SYK) has scheduled its 2025 Annual Meeting of Shareholders for Thursday, May 8, 2025, at 9:30 a.m. Eastern Time. The meeting will be conducted virtually via the internet.
Shareholders can access the webcast, including audio and slide presentation, through the company's Investor Relations page at www.investorevents.stryker.com. For audio-only participation, attendees can dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker Annual Meeting."
A recording will be available from 10:30 a.m. ET on May 9, 2025, at www.virtualshareholdermeeting.com/SYK2025 until the 2026 proxy statement filing.